Patents by Inventor Eugene A. Cameron

Eugene A. Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220008926
    Abstract: The present invention provides microfluidic devices capable of sequestering single particles in individual microchambers and isolating the particles from one another. The devices provide a plurality of channels fluidly connected to a plurality of microchambers. A fluid suspension comprising particles of interest can be passed through the devices in a first direction to sequester single particles in each microchamber. An isolating fluid can be passed through the devices in a second, reverse direction to isolate the particles from one another. The devices can selectively isolate several particles in each microchamber.
    Type: Application
    Filed: July 6, 2021
    Publication date: January 13, 2022
    Applicant: The Penn State Research Foundation
    Inventors: Craig Eugene Cameron, Wu Liu
  • Patent number: 6448280
    Abstract: This invention relates to the use of angiotensin II antagonists in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity, such as diabetic neuropathy, as well as their use in the manufacture of a medicament for use in such treatment. The invention also concerns pharmaceutical compositions containing an angiotensin II antagonist together with one or more other agents known to be of value in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity.
    Type: Grant
    Filed: January 5, 1995
    Date of Patent: September 10, 2002
    Assignee: Zeneca Limited
    Inventors: Frank Carey, Alexander Anthony Oldham, Norman Eugene Cameron, Mary Anne Cotter
  • Patent number: 6337327
    Abstract: The invention relates to pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor, and their use in the treatment of diabetic complications such as diabetic neuropathy, diabetic retinopathy and diabetic nephropathy.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: January 8, 2002
    Assignee: Zeneca Limited
    Inventors: David Patrick Tuffin, Frank Carey, Mary Anne Cotter, Norman Eugene Cameron
  • Patent number: 4213005
    Abstract: A system for precisely determining the location of a cursor on a work surface with respect to a grid of coordinate conductors. The system is based on the time-distance relationship of current sheets caused to move sequentially along each axis of the work surface, and the detection of each current sheet as it approaches and passes an operator-movable sensor. A number of the grid wires are simultaneously energized with a fixed energization pattern which steps along the conductors, thereby generating the current sheet and consequent magnetic field which translate along the plane of the conductors parallel to the conductors. A preferred means responsive to the time of passage of the current sheet comprises an inductive pickup coil having a diameter approximately equal to the width of the current sheet and means for sensing current induced in the pickup coil. Preferably, the grid conductors are energized with substantially fixed constant currents.
    Type: Grant
    Filed: December 13, 1978
    Date of Patent: July 15, 1980
    Inventor: Eugene A. Cameron